DE69727155D1 - Dimesylatsalze von neuropeptiden und liganden - Google Patents

Dimesylatsalze von neuropeptiden und liganden

Info

Publication number
DE69727155D1
DE69727155D1 DE69727155T DE69727155T DE69727155D1 DE 69727155 D1 DE69727155 D1 DE 69727155D1 DE 69727155 T DE69727155 T DE 69727155T DE 69727155 T DE69727155 T DE 69727155T DE 69727155 D1 DE69727155 D1 DE 69727155D1
Authority
DE
Germany
Prior art keywords
neuropeptides
ligands
dimesylate
salts
dimesylate salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69727155T
Other languages
English (en)
Other versions
DE69727155T2 (de
Inventor
J Allen
R Brostrom
S Kord
A Whipple
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69727155D1 publication Critical patent/DE69727155D1/de
Application granted granted Critical
Publication of DE69727155T2 publication Critical patent/DE69727155T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69727155T 1996-11-26 1997-11-19 Dimesylatsalze von neuropeptiden und liganden Expired - Fee Related DE69727155T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26
US31815P 1996-11-26
PCT/IB1997/001465 WO1998023603A1 (en) 1996-11-26 1997-11-19 Dimesylate salts of neuropeptide y ligands

Publications (2)

Publication Number Publication Date
DE69727155D1 true DE69727155D1 (de) 2004-02-12
DE69727155T2 DE69727155T2 (de) 2004-07-08

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727155T Expired - Fee Related DE69727155T2 (de) 1996-11-26 1997-11-19 Dimesylatsalze von neuropeptiden und liganden

Country Status (23)

Country Link
US (1) US5914329A (de)
EP (1) EP0944611B1 (de)
JP (1) JP3120861B2 (de)
AP (1) AP9701148A0 (de)
AR (1) AR010304A1 (de)
AT (1) ATE257472T1 (de)
AU (1) AU4792497A (de)
BR (1) BR9713538A (de)
CA (1) CA2272927C (de)
DE (1) DE69727155T2 (de)
DK (1) DK0944611T3 (de)
ES (1) ES2213207T3 (de)
GT (1) GT199700123A (de)
HN (1) HN1997000154A (de)
HR (1) HRP970640A2 (de)
ID (1) ID18964A (de)
MA (1) MA26450A1 (de)
PA (1) PA8441701A1 (de)
PE (1) PE17099A1 (de)
PT (1) PT944611E (de)
TN (1) TNSN97191A1 (de)
WO (1) WO1998023603A1 (de)
ZA (1) ZA9710587B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
CN1630514A (zh) 2001-12-05 2005-06-22 贝勒医学院 通过调节交感神经紧张性控制骨形成的方法和组合物
NZ533848A (en) 2002-01-09 2006-11-30 Arexis Ab Detection of mutations in the flavin-containing monooxygenase (FMO3) gene
WO2006057507A1 (en) * 2004-11-23 2006-06-01 Dong Wha Pharm.Ind.Co., Ltd An oral preparation having improved bioavailability
EP1877076A4 (de) * 2005-04-15 2012-02-01 Regenertech Pty Ltd Verwendung von neuropeptid y (npy) sowie von agonisten und antagonisten davon zur geweberegeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509610A (pt) * 1994-11-07 1997-10-28 Pfizer Ligandos específicos de neuropeptideo Y1

Also Published As

Publication number Publication date
ZA9710587B (en) 1999-05-25
ID18964A (id) 1998-05-28
US5914329A (en) 1999-06-22
AP9701148A0 (en) 1998-01-31
EP0944611B1 (de) 2004-01-07
MA26450A1 (fr) 2004-12-20
AU4792497A (en) 1998-06-22
JP2000505110A (ja) 2000-04-25
CA2272927A1 (en) 1998-06-04
JP3120861B2 (ja) 2000-12-25
DK0944611T3 (da) 2004-04-13
HN1997000154A (es) 1999-02-09
PA8441701A1 (es) 2000-05-24
EP0944611A1 (de) 1999-09-29
AR010304A1 (es) 2000-06-07
GT199700123A (es) 1999-05-19
WO1998023603A1 (en) 1998-06-04
PT944611E (pt) 2004-04-30
TNSN97191A1 (fr) 2005-03-15
DE69727155T2 (de) 2004-07-08
ATE257472T1 (de) 2004-01-15
HRP970640A2 (en) 1998-10-31
CA2272927C (en) 2003-02-04
PE17099A1 (es) 1999-02-19
ES2213207T3 (es) 2004-08-16
BR9713538A (de) 2000-03-21

Similar Documents

Publication Publication Date Title
DE69803199D1 (de) Erkennung und entfernung von makroviren
DE69736664D1 (de) Segmentierung und wiederzusammensetzung von minizellen
DE69422791D1 (de) Sendung und Empfang von Programminformation
DE69813233T2 (de) Hydrocyanierung von diolefinen und isomierung von nicht-konjugierten 2-alkyl-3-monoalkennitrilen
DE69727218D1 (de) Einschluss komplexe von aryl-heterokyhlishe salzen
DE69533361D1 (de) Umsetzung von kohlenwasserstoffen
NO972625D0 (no) Fibrin-tetningsapplikator
DE69728779D1 (de) Entfernung von fältchen
ID19422A (id) Piridina dan bifenil tersubstitusi
ATA116194A (de) Fluxbitumen und bitumenemulsion
DE69841295D1 (de) Regenerierung von In-Phase- und Quadratursignalen
DE69718231D1 (de) Schnitt von aufgezeichnetem Material
DE69501493D1 (de) Entfernung von Feuchtigkeit und Passivierung von Oberflächen
DE69702805T2 (de) Vielseitige Massstabsveränderung von Zeichnungen
DE59507427D1 (de) Mischkristalle und feste Lösungen von 1,4-Diketopyrrolopyrrolen
DE69506350T2 (de) Erfassung des Zustandes von Aufzeichnungsträgern
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
DE69814100D1 (de) Verschluss von absorbierenden artikeln
DE69517289T2 (de) Verfahren zur Aktivierung von Ton und aktiviertem Ton
DE69717677D1 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether
DE69500881T2 (de) Oxidation von uranhexafluorid
DE69524590T2 (de) Zusammensetzung von 5htida und 5htid antagonisten
DE69727155D1 (de) Dimesylatsalze von neuropeptiden und liganden
DE69508165D1 (de) Strickschlussteil und Schluss
DE69709159D1 (de) Kreuz-dimierisierung von olefinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee